Literature DB >> 25858356

Extremely high prevalence of antiseptic resistant Quaternary Ammonium Compound E gene among clinical isolates of multiple drug resistant Acinetobacter baumannii in Malaysia.

Mohammad Babaei, Anita Sulong, Rukman Hamat, Syafinaz Nordin, Vasantha Neela.   

Abstract

BACKGROUND: Antiseptics are commonly used for the management of MDR (multiple drug resistance) pathogens in hospitals. They play crucial roles in the infection control practices. Antiseptics are often used for skin antisepsis, gauze dressing, preparation of anatomical sites for surgical procedure, hand sterilization before in contact with an infected person, before an invasive procedure and as surgical scrub.
METHODS: We screened 122 multiple drug resistant Acinetobacter baumannii (MDRAB) isolated from admitted patients in one of the tertiary care hospital in Malaysia for the presence of antiseptic resistant genes qacA and qacE (Quaternary Ammonium Compound) and susceptibility towards chlorhexidine (CLX), benzalkonium (BZK) and benzethonium (BZT).
RESULTS: Eighty-nine (73%) isolates harboured qacE gene, while none were positive for qacA. The MIC ranged from 0.2 to 0.6 for CLX, 0.02 to 0.2 for BZK and 0.04 to 0.2 μg/mL for BZT. The highest number of qacE positive isolates were obtained from surgery (n = 24; 27%; p < 0.05), followed by medical ward (n = 23; 25.8%) and ICU (n = 21; 23.6%). Majority of the isolates from wound swabs (n = 33; 37%), T/aspirate (n = 16; 18%) and tissue (n = 10; 11.2%) harboured the qacE genes.
CONCLUSION: The present investigation showed high prevalence of qacE gene among the studied isolates. Antiseptics are important components of infection control, continuous monitoring of antiseptics use in the hospital is cautioned.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25858356      PMCID: PMC4363066          DOI: 10.1186/s12941-015-0071-7

Source DB:  PubMed          Journal:  Ann Clin Microbiol Antimicrob        ISSN: 1476-0711            Impact factor:   3.944


Background

Multiple drug resistance Acinetobacter baumannii (MDRAB) ranks top among the nosocomial pathogen due to their environmental elasticity, ability to colonize various body sites of hospitalized patients, long-time persistence, association with multiple drug resistance and their successful outbreak potential [1-5]. It causes a wide spectrum of nosocomial infections which includes infections of bloodstream, urinary and respiratory tract, and ventilator associated pneumonia commonly among Intensive Care Unit patients (ICU) [6,7]. The main sources of transmission implicated with A. baumannii infections are person to person contact or through contaminated surface [8] and previous room occupancy by patients with A. baumannii infection or colonization. Epidemiological studies have clearly shown that hospital environment and colonized patients as the major reservoirs of A. baumannii infections [9]. Management of A. baumannii infections is the greatest challenge for patients, clinicians and infection control physicians. Infection control interventions such as patient screening, cohort isolation, hand hygiene compliance, surveillance of environmental contamination, enhanced cleaning and environmental disinfection have been shown to reduce nosocomial infection rates and outbreaks due to A. baumannii in various studies [4,10,11]. Antiseptics are increasingly used in hospitals to control the dissemination of nosocomial infections. The regular use of antiseptics in hospital has raised concerns about its resistance. A very recent study by Suwantarat [12] has shown that bacteria causing life threatening infections in seriously ill patients are now becoming less susceptible to the commonly used antiseptics in the hospital. The study compared patients in ICU who received daily antiseptic washes with non ICU patients who did not receive any antiseptic baths. It was found that patients who received regular antiseptics baths showed less susceptibility to CLX compared to those who did not receive any antiseptic washes. Antiseptic resistance is encoded by the qac genes. To date several qac genes such as qac A/B genes [13-15], qac C/D also known as smr [15], qacE/F [16,17], qacG [18], qacH [19,20], qac J [21,22] and qac Z [23,24] have been reported. Qac A/B followed by qac C/D genes is frequently associated with gram positive [25] and [26], while qac E is commonly seen in gram negative bacteria. Several studies from Asia including Malaysia have shown continuous increase of highly multiple drug resistant A. baumannii in Asia [27-30]. A recent study [27] demonstrated correlation between reduced susceptibility to disinfectants and multidrug resistance among clinical isolates of Acinetobacter species. Although several studies have shown the prevalence of antibiotic resistance in A. baumanni, only very few reports are available on the antiseptic and disinfectant susceptibility. In Malaysia, despite, A. baumannii being one of the serious nosocomial pathogen, its susceptibility towards antiseptics and disinfectant is largely unknown. Therefore, in this study we investigated the antiseptic and disinfectant susceptibility and carriage of corresponding resistant genes in A. baumannii isolated from patients admitted in one of the tertiary care teaching hospital in Malaysia. The study was conducted in Universiti kebangsan Malaysia Medical Centre, as it is in the capital of the country, which receives population from all over Malaysia. The rising trends of A. baumannii infections in the hospital prompted to investigate the antiseptic and disinfectant susceptibility.

Methods

Bacterial isolates

A total of 122 non-repetitive multiple drug resistance Acinetobacter baumannii (MDRAB) isolates collected from various clinical specimens (5 from blood, 41 wound swabs, 26 tracheal aspirate, 14 urine, 14 tissue, 10 sputum, 12 from others) from February 2012 to January 2013 from a 900 bedded hospital UKMMC was investigated. The isolates were confirmed in the hospital by the standard microbiological methods and also by AP 20NE (bioMérieux, France). The isolates were reconfirmed as A. baumannii by standard methods (oxidase, catalase, TSI, MRVP, Simmon citrate, motility, urease and Gram staining) in our laboratory stationed at Department of Medical Microbiology and Parasitology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia. An isolate is defined as MDRAB when it is resistant to more than three classes of antibiotics tested by disc diffusion test.

PCR assay for qacA and qacE

Total genomic DNA was extracted from MDRAB isolates using GF-1 Bacterial DNA Extraction Kit (Vivantis Technologies, Malaysia). All isolates were screened for the presence of qacA [31] (5′GCAGAAAGTGCAGAGTTCG-3′ and 5′ TCAACCGAATAGAGTGAACTTATCT-3′) and qacE [32] (QacE F: 5′-GCGAAGTAATCGCAACATCC-3′ and Qac E R: 5′ GCCCCATACCTACAAAGCC-3′) genes. Two representative isolates for each gene was sequenced (First BASE Laboratories, Malaysia) and used as positive control. The sequence of the genes were confirmed by blastN program in GenBank (http://www.ncbi.nlm.nih.gov).

Antiseptic susceptibility

All antiseptics chlorhexidine (CLX), benzalkonium (BZK) and benzethonium (BZT) were purchased from Sigma Aldrich (St Louis, MO, USA). A stock of antiseptics containing 100 mg/L of CLX, BZK and BZT in deionized water was prepared and stored at 4°C. MICs of antiseptics were determined by the broth microdilution method according to the Clinical and Laboratory Standards Institute [1]. Since there was no standard breakpoints available for antiseptics against A. baumannii, we tested a 2 fold dilutions from 4% to 0.00006%. A standard bacterial concentration of McFarland Standard 0.5 (1.5 × 108 CFU/mL) was used. Briefly 50 μl of bacterial suspension was added from well one to twelve in a 96 well plate. To well one, 50 μl of 4% antiseptics was added. Upon mixing well, 50 μl was transferred to next well and continued until last well. The dilutions included 4%, 2%, 1%, 0.5%, 0.25%, 0.125%, 0.0625%, 0.0312%, 0.0156%, 0.0078%, 0.0039% and 0.0019%. Susceptibility was interpreted based on the turbidity on the inoculum after incubation at 37°C for 24 hrs.

Results

Among the 122 isolates tested, qacE was found to be present in 89 isolates (72.95%), none of the isolates carried qacA gene. In general for qacA positive isolates, the MIC ranged from 0.2 to 0.6 μg/mL for CLX, 0.02 to 0.2 μg/mL for BZK and 0.04 to 0.2 μg/mL for BZT. For qacE negative isolates, MIC ranged from 0.04 to 0.3 μg/mL for CLX, 0.01 for 0.08 μg/mL for BZK and 0.02 to 0.08 μg/mL for BZT. Highest qacE positive isolates were obtained from surgery (n = 24; 27%), followed by medical ward (n = 23; 25.8%) and ICU (n = 21; 23.6%) as illustrated in Tables 1 and 2. Isolation of qacE positive MDRAB was found to be significantly higher in the surgical ward (p < 0.05). Majority of the isolates from wound swabs (n = 33; 37%), T/aspirate (n = 16/18%) and tissue (n = 10/11.2%) harboured the qacE genes.
Table 1

Isolation of positive MDRAB from different wards

Ward Number of isolates (%)
qacE positive (n = 89) P value
ICU21 (23.6%)>0.05
Neurosurgery2 (2.2%)>0.05
Orthopaedics7 (7.9%)>0.05
Urology4 (4.5%)>0.05
Surgery24 (27%) <0.05*
Medical23 (25.8%)>0.05
Burn2 (2.3%)>0.05
Others6 (6.7%)>0.05

<0.05*Indicates statistically significant.

Table 2

Isolation of positive MDRAB from different clinical specimens

Clinical specimens qacE positive (n = 89) P value
Tracheal aspirate16 (18%)>0.05
Wound swabs33 (37%)>0.05
Tissue10 (11.2%)>0.05
Blood4 (4.5%)>0.05
Urine13 (14.6%)>0.05
Sputum6 (6.8%)>0.05
Others7 (7.9%)>0.05
Isolation of positive MDRAB from different wards <0.05*Indicates statistically significant. Isolation of positive MDRAB from different clinical specimens

Discussion

MDRAB is the biggest challenge for the infection control unit in every hospital setting. Growing resistance to every licensed antimicrobial agent against MDRAB including carbapenems to date has made this organism of global concern. Resistance rates may likely increase the treatment failures and mortality rates [29,30]. Unfortunate acquisition of MDRAB that leads to life threatening blood stream infections and pneumonia in the hospital could be prevented if proper hygienic measures are implemented, practiced and monitored regularly. Antiseptics are widely used for infection control. They are applied to living tissue to reduce the possibility of infection, sepsis, or putrefaction and especially to keep the environment and the inanimate objects clean (for e.g. ventilators, catheter) from microbial communities. In the studied hospital, we found majority of the MDRAB isolates 89 (73%) to harbour the qacE gene. However, the MIC for all the QAC’s tested was far less than the concentration used in the hospitals (0.5%–4% mL/liter) [33]. A study [34] showed higher MIC for S. aureus that harboured qacA/B gene. In the current study for MDRAB, no significant difference (p > 0.05) was observed in MIC for qacE positive and negative isolates. The high carriage of qacE positive MDRAB in surgical ward (p < 0.05) is not surprising as it is known that antiseptics are very frequently used in surgical wards to reduce the skin and soft tissue infections and also to reduce the postsurgical length of stay and duration of antibiotic therapy [3]. Central venous (CV) catheters are commonly used in the ICU as it plays crucial role in the management of critically ill patients. In the current study, we found that majority of MDRAB isolates from ICU harbour qacE gene. Although the use of antiseptic impregnated catheters reduces catheter related bloodstream infections, emergence of antiseptic resistant strains are still on the rise. A recent study [34] reported high rates of qacA and qacB positive MRSA isolation from chlorhexidine impregnated catheter related bloodstream infections. Stable resistance for antiseptics and antibiotics could be obtained for MDRAB when they are exposed step-wise with gradually increasing concentrations of QAC’s as seen in Pseudomonas aeuroginosa and Eschericia coli [34,12]. This has also been shown in a metagenomic study which revealed that microbial community adapts to QAC when continuously exposed. A recent review has shown increasing evidence for co resistance and cross resistance between QAC’s and other important antibiotics and disinfectants.

Limitations of the study

The main limitation of the study was samples from only one hospital in Malaysia were studied. As very limited data on antibiotic resistance pattern was available, antiseptic and antibiotic resistance could not be compared.

Conclusions

In conclusion, although the MIC of the QAC’s tested against MDRAB is much lower than the concentration used in the hospital, the high prevalence of qacE gene in the studied isolates warns the continuous monitoring of antiseptics use in the hospital.
  28 in total

1.  Detection of qacA/B in clinical isolates of methicillin-resistant Staphylococcus aureus from a regional healthcare network in the eastern United States.

Authors:  Patrick McGann; Yoon I Kwak; Amy Summers; James F Cummings; Paige E Waterman; Emil P Lesho
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09-20       Impact factor: 3.254

2.  Chromosome- and plasmid-mediated gentamicin resistance in Staphylococcus aureus encoded by Tn4001.

Authors:  M T Gillespie; B R Lyon; L J Messerotti; R A Skurray
Journal:  J Med Microbiol       Date:  1987-09       Impact factor: 2.472

3.  First detection of the antiseptic resistance gene qacA/B in Enterococcus faecalis.

Authors:  Meike Bischoff; Johann Bauer; Petra Preikschat; Karin Schwaiger; Gabriele Mölle; Christina Hölzel
Journal:  Microb Drug Resist       Date:  2011-10-21       Impact factor: 3.431

Review 4.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

5.  High prevalence of reduced chlorhexidine susceptibility in organisms causing central line-associated bloodstream infections.

Authors:  Nuntra Suwantarat; Karen C Carroll; Tsigereda Tekle; Tracy Ross; Lisa L Maragakis; Sara E Cosgrove; Aaron M Milstone
Journal:  Infect Control Hosp Epidemiol       Date:  2014-07-23       Impact factor: 3.254

6.  Involvement, and dissemination, of the enterococcal small multidrug resistance transporter QacZ in resistance to quaternary ammonium compounds.

Authors:  Teresa M Braga; Paulo E Marujo; Constança Pomba; M Fátima Silva Lopes
Journal:  J Antimicrob Chemother       Date:  2010-12-08       Impact factor: 5.790

7.  High rate of qacA- and qacB-positive methicillin-resistant Staphylococcus aureus isolates from chlorhexidine-impregnated catheter-related bloodstream infections.

Authors:  Cheng-Mao Ho; Chi-Yuan Li; Mao-Wang Ho; Chien-Yu Lin; Shu-Hui Liu; Jang-Jih Lu
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

Review 8.  Acinetobacter outbreaks, 1977-2000.

Authors:  Maria Virginia Villegas; Alan I Hartstein
Journal:  Infect Control Hosp Epidemiol       Date:  2003-04       Impact factor: 3.254

9.  Novel plasmid-borne gene qacJ mediates resistance to quaternary ammonium compounds in equine Staphylococcus aureus, Staphylococcus simulans, and Staphylococcus intermedius.

Authors:  Jostein Bjorland; Terje Steinum; Marianne Sunde; Steinar Waage; Even Heir
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  Reduction in surgical site infections in neurosurgical patients associated with a bedside hand hygiene program in Vietnam.

Authors:  Thi Anh Thu Le; Michael J Dibley; Van Nho Vo; Lennox Archibald; William R Jarvis; Annette H Sohn
Journal:  Infect Control Hosp Epidemiol       Date:  2007-04-05       Impact factor: 3.254

View more
  9 in total

1.  Peptide-Based Efflux Pump Inhibitors of the Small Multidrug Resistance Protein from Pseudomonas aeruginosa.

Authors:  Chloe J Mitchell; Tracy A Stone; Charles M Deber
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

Review 2.  Biological activity of quaternary ammonium salts and resistance of microorganisms to these compounds.

Authors:  Ewa Obłąk; Bożena Futoma-Kołoch; Anna Wieczyńska
Journal:  World J Microbiol Biotechnol       Date:  2021-01-11       Impact factor: 3.312

3.  Evaluating the Effectiveness of Hospital Antiseptics on Multidrug-Resistant Acinetobacter baumannii: Understanding the Relationship between Microbicide and Antibiotic Resistance.

Authors:  Melanie Betchen; Holly M Giovinco; Michael Curry; Jackson Luu; Henry Fraimow; Valerie J Carabetta; Raquel Nahra
Journal:  Antibiotics (Basel)       Date:  2022-05-03

4.  High Prevalence of blaNDM-1, blaVIM, qacE, and qacEΔ1 Genes and Their Association with Decreased Susceptibility to Antibiotics and Common Hospital Biocides in Clinical Isolates of Acinetobacter baumannii.

Authors:  Fatma Alzahraa M Gomaa; Zeinab H Helal; Mazhar I Khan
Journal:  Microorganisms       Date:  2017-04-12

5.  Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?

Authors:  Martin Exner; Sanjay Bhattacharya; Bärbel Christiansen; Jürgen Gebel; Peter Goroncy-Bermes; Philippe Hartemann; Peter Heeg; Carola Ilschner; Axel Kramer; Elaine Larson; Wolfgang Merkens; Martin Mielke; Peter Oltmanns; Birgit Ross; Manfred Rotter; Ricarda Maria Schmithausen; Hans-Günther Sonntag; Matthias Trautmann
Journal:  GMS Hyg Infect Control       Date:  2017-04-10

6.  Comparative genomic analysis and multi-drug resistance differences of Acinetobacter baumannii in Chongqing, China.

Authors:  Ling Pu; Zuoyi Jian; Fen Pan; Yang Geng; Miao He; Pu Liao
Journal:  Infect Drug Resist       Date:  2019-09-11       Impact factor: 4.003

7.  Upregulation of abeM, amvA, and qacEΔ1 efflux pump genes associated with resistance of Acinetobacter baumannii strains to disinfectants.

Authors:  Tahereh Rostami; Mojtaba Ranjbar; Sedighe Ghourchian; Fatemeh Darzi; Masoumeh Douraghi; Mahmoud Nateghi-Rostami
Journal:  Health Sci Rep       Date:  2021-10-01

8.  Phenotype and genetic determination of resistance to common disinfectants among biofilm-producing and non-producing Pseudomonas aeruginosa strains from clinical specimens in Iran.

Authors:  Mehdi Bakht; Safar Ali Alizadeh; Sara Rahimi; Raana Kazemzadeh Anari; Mohammad Rostamani; Amir Javadi; Amir Peymani; Seyed Mahmoud Amin Marashi; Farhad Nikkhahi
Journal:  BMC Microbiol       Date:  2022-05-07       Impact factor: 4.465

9.  Molecular Characterization of Reduced Susceptibility to Biocides in Clinical Isolates of Acinetobacter baumannii.

Authors:  Fei Lin; Ying Xu; Yaowen Chang; Chao Liu; Xu Jia; Baodong Ling
Journal:  Front Microbiol       Date:  2017-09-26       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.